StockTipsArenaBeta

BUY Krishna Institute of Medical Sciences Limited — Axis Securities

BUYKrishna Institute of Medical Sciences Limited

byAxis SecuritiesHorizon: NA (inferred 1–3 months)19 Aug 2026via Economic Times New Stock Recos

Entry₹788.65Inferred
Target₹890
Total upside +12.85%
Stop lossNot given
CMP₹764.5513h ago
Active-3.06%+16.41%upside left 2 mo left
Follow Axis Securities for new callsGet alertsWatch KIMS for new buy/sell callsGet alertsSee 1 other Short-term call on KIMSSee 16 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 6:08 am IST
8 supporting7 neutral2 opposing
Supports the BUY call (8)

This hospital stock could hit ₹1,000 over the next 12 months, Investec predicts with a 'buy' rating

NewsCnbc-Tv18·3 Sept · 4d ago

(opens in new tab)

3 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Aug · 1w ago

Entered into Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited.

NSE · Agreements·20 Aug · 3w ago

(opens in new tab)

KIMS entered into Operations and Management agreement with Aurevia Hospitals Private Limited.

BSE · Company Update·20 Aug · 3w ago

(opens in new tab)

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·9 Jun · 3mo ago

Neutral / worth noting (7)

Indian Hospital Chains Expand Capacity Despite Staffing Crunch

NewsGoogle News·27 Aug · 2w ago

(opens in new tab)

KIMS to operate 250-bed Arete Hospital in Hyderabad under 5-year O&M deal

NewsCnbc-Tv18·20 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·8 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.